Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Baroncini, D.
478  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: A..:

Sormani M. P ; Schiavetti I ; Landi D...
info:eu-repo/semantics/altIdentifier/pmid/34328824.  , 2022
Link: http://hdl.handle.net/11..
 
?
2

A real-world study of alemtuzumab in a cohort of Italian pa..:

Russo C. V ; Sacca F ; Frau J...
info:eu-repo/semantics/altIdentifier/pmid/34558755.  , 2022
Link: http://hdl.handle.net/11..
 
?
3

Magnetically controlled growing rods in the management of e..:

Migliorini F ; Chiu W. O ; Scrofani R...
info:eu-repo/semantics/altIdentifier/pmid/35690867.  , 2022
Link: https://hdl.handle.net/1..
 
?
4

Surgical management of focal chondral defects of the knee: ..:

Migliorini, F ; Eschweiler, J ; Schenker, H...
https://eprints.keele.ac.uk/id/eprint/10201/1/s13018-021-02684-z.pdf.  , 2021
Link: https://eprints.keele.ac..
 
?
5

Autologous Matrix-Induced Chondrogenesis (AMIC) and Microfr..:

Migliorini, F ; Eschweiler, J ; Maffulli, N...
https://eprints.keele.ac.uk/id/eprint/9385/1/life-11-00183-v2.pdf.  , 2021
Link: https://eprints.keele.ac..
 
?
6

Etiological research in pediatric multiple sclerosis: A too..:

Pilotto S ; Gencarelli J ; Bova S...
info:eu-repo/semantics/altIdentifier/pmid/34868629.  , 2021
Link: http://hdl.handle.net/11..
 
?
7

Cladribine vs other drugs in MS: Merging randomized trial w..:

Signori A ; Sacca F ; Lanzillo R...
info:eu-repo/semantics/altIdentifier/pmid/32801167.  , 2020
Link: http://hdl.handle.net/11..
 
?
8

Cladribine vs other drugs in MS: Merging randomized trial w..:

Signori A ; Sacca F ; Lanzillo R...
info:eu-repo/semantics/altIdentifier/pmid/32801167.  , 2020
Link: https://hdl.handle.net/1..
 
?
9

Cladribine vs other drugs in MS: Merging randomized trial w..:

Signori A ; Sacca F ; Lanzillo R...
info:eu-repo/semantics/altIdentifier/pmid/32801167.  , 2020
Link: http://hdl.handle.net/23..
 
?
10

Clinical trials of disease-modifying agents in pediatric MS..:

Waubant E ; Banwell B ; Wassmer E...
info:eu-repo/semantics/altIdentifier/pmid/31043474.  , 2019
Link: http://hdl.handle.net/11..
 
?
11

Survey of Italian pediatricians on awareness, experiences a..:

Baroncini A ; Torricelli F ; Cocchi G.
info:eu-repo/semantics/altIdentifier/wos/WOS:000461994400008.  , 2019
Link: http://hdl.handle.net/10..
 
?
12

Comparative effectiveness of Cladribine tablets vs other dr..:

Signori, A ; Sacca, F ; Lanzillo, R...
info:eu-repo/semantics/altIdentifier/wos/WOS:000485303102162.  , 2019
Link: http://hdl.handle.net/23..
 
?
13

Erste Ergebnisse der dynamischen Skoliosekorrektur bei 29 P..:

Baroncini, A ; Trobisch, P
http://dx.doi.org/10.3205/19dkou603.  , 2019
Link: https://doi.org/10.3205/..
 
?
14

Determinants of therapy switch in multiple sclerosis treatm..:

Sacca F ; Lanzillo R ; Signori A...
info:eu-repo/semantics/altIdentifier/pmid/30044207.  , 2019
Link: http://hdl.handle.net/23..
 
?
15

Shift from fingolimod to alemtuzumab: what happens next?:

Frau, J ; Sacca, F ; Signori, A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000446861400152.  , 2018
Link: http://hdl.handle.net/23..
 
1-15